# IMJUDO
> **BLA761289** · Biologics License Application · Sponsor: ASTRAZENECA AB · Approved 2022-10-21
## Drug
- **FDA Application Number:** BLA761289
- **Application type:** Biologics License Application
- **Brand name:** IMJUDO
- **Generic name:** TREMELIMUMAB
- **Active ingredients:** TREMELIMUMAB-ACTL
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA AB
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2022-10-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761289)
---
*MORVS · CC0 1.0*